Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0
|
|
- Dominick Collins
- 5 years ago
- Views:
Transcription
1 Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0 January 2016
2 Summary. This policy applies only to selected staff within the Haematology Department at the Royal Cornwall Hospital Trust and to Haematology Nurse Specialists as identified by the Lead Haematology Consultant. All training, education and governance procedures contained within the Blood Transfusion Policy must be adhered to. The Consultant Haematologist (MRC Path Haematology or equivalent): o is responsible for monitoring the patient s progress o is responsible for drawing up a clear plan of treatment for patients requiring transfusion of red cells or platelets. o will act as mentor and assessor and must be up-to-date with mandatory transfusion training. The nurse authoriser o will approach a consultant Haematologist (with responsibility for Transfusion on HTT) as a mentor and assessor. o will be responsible for gaining adequate knowledge and experience prior to assessment and must be up-to-date with mandatory transfusion training. o will demonstrate competence during a period of supervised practice and signed off by the responsible consultant o must attend NHSBT approved training Non-Medical Authorisation of Blood components, to be able to apply for the training they must have at least 3 years experience relevant to transfusion, and approval and support from the Lead Consultant Haematologist Patients must have a Haematology diagnosis Page 2 of 10
3 Table of Contents Summary Introduction Purpose of this Policy/Procedure Scope Ownership and Responsibilities Role of the Hospital Transfusion Committee (HTC) Role of Individual Staff Standards and Practice Training Patient Selection Dissemination and Implementation Monitoring compliance and effectiveness Updating and Review Equality and Diversity Equality Impact Assessment... 6 Appendix 1. Governance Information... 7 Appendix 2. Initial Equality Impact Assessment Form... 9 Page 3 of 10
4 1. Introduction 1.1. A collaborative project was undertaken by NHS Blood and Transplant and the Scottish National Blood Transfusion Service to investigate the prescribing or more properly the authorisation of blood transfusions by nurses and midwives. Section 130 of the 1968 Medicines Act has been amended by Section 25 of the Blood Safety and Quality Regulations 2005 (SI2005 no 50). In effect this means that Blood and Blood Components (Red Cells, Platelets, Fresh Frozen Plasma and Cryoprecipitate) are excluded from a legal definition of medicinal products and therefore cannot be prescribed by any practitioner. There is therefore no legal barrier to nurses authorising a blood transfusion. Following wide consultation, a Governance Framework was developed to support this role development. 2. Purpose of this Policy/Procedure 2.1. In responding to the changing needs of patients and clinical practice, some senior and experienced nurses have been considered in authorising blood transfusions It is expected that the patient will benefit due to: A reduced delay in the decision to transfuse A reduced delay in authorising the transfusion The decision to transfuse will be made by an experienced nurse who has an in-depth knowledge of the patients undergoing regular transfusion 2.3. This policy establishes the criteria and assessment framework required for the authorisation of red cells and platelets by nurse authorisers. 3. Scope 3.1. This policy applies only to selected staff within the Haematology Department at the Royal Cornwall Hospital Trust and to Haematology Nurse Specialists as identified by the Lead Haematology Consultant This policy supplements the RCHT Blood Transfusion Policy. All training, education and governance procedures contained within the Blood Transfusion Policy must be adhered to. 4. Ownership and Responsibilities 4.1. Role of the Hospital Transfusion Committee (HTC) This policy will be ratified by the HTC HTC will be responsible for monitoring any recommendations arising from reviews of practice / audit reports and these will be documented within the minutes of the meeting. Page 4 of 10
5 4.2. Role of Individual Staff Consultant haematologist: The Consultant Haematologist is responsible for monitoring the patient s progress. The Consultant Haematologist is responsible for drawing up a clear plan of treatment for patients requiring transfusion of red cells or platelets. The Consultant Haematologist (MRC Path Haematology or equivalent) will act as mentor and assessor, and must be up-todate with mandatory transfusion training Nurse Authoriser: The nurse authoriser will approach a consultant Haematologist (with responsibility for Transfusion on HTT) as a mentor and assessor. The nurse authoriser will be responsible for gaining adequate knowledge and experience prior to assessment and must be up-todate with mandatory transfusion training. The nurse authoriser will demonstrate competence during a period of supervised practice and signed off by the responsible consultant. 5. Standards and Practice 5.1. Training The nurse authoriser must attend NHSBT approved training Non- Medical Authorisation of Blood components, to be able to apply for the training they must have at least 3 years experience relevant to transfusion, and approval and support from the Lead Consultant Haematologist The training will include: Overview of blood components Transfusion reactions Significance of antibodies and appropriate blood selection BCSH administration guidelines, documentation and reporting of incidents Legal requirements Appropriateness, indications for transfusion and Hb triggers. Scenarios 5.2. Patient Selection Patients must have a Haematology diagnosis Transfusion must be indicated as per the Blood Transfusion Policy Page 5 of 10
6 6. Dissemination and Implementation 6.1. All relevant clinicians and lab staff will be informed of enhanced role and policy changes Not relevant to other staff. All training identified above. 7. Monitoring compliance and effectiveness Element to be monitored Lead Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared Incidents or adverse events involving blood transfusion are reported and monitored through Datix. Prescribing/authorising practice with regard to compliance to the policy will be monitored. Haem consultant and Haematology Transfusion Team (HTT) The Datix reporting system will be used to monitor incidents. There is currently no tool to monitor compliance. When appropriate data can be collected via NCA AFFINITE Monitoring will be ongoing through existing governance strategies in the haematology laboratory. There will be a review of practice at 6 and 12 months, an audit will be completed and report produced two yearly thereafter. The report will be presented to the HTC/HTT. HTC/HTT will be responsible for making any recommendations, these will be documented within the minutes of the meeting. HTC/HTT will be responsible for making any recommendations, these will be documented within the minutes of the meeting. Required changes to practice will be agreed by HTC/HTT and Haematology CNS. All relevant clinicians, lab staff and nursing staff will be informed either by or at staff meetings. 8. Updating and Review 8.1. This policy will be updated at least every 3 years Any amendments or working changes will be assessed and agreed by the Haematology Transfusion Team. 9. Equality and Diversity 9.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the 'Equality, Diversity & Human Rights Policy' or the Equality and Diversity website Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendix 2. Page 6 of 10
7 Appendix 1. Governance Information Document Title Date Issued/Approved: January 2016 Date Valid From: January 2016 Date Valid To: January 2019 Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist Directorate / Department responsible (author/owner): Caroline Edwards, Haematology CNS, CSSC Contact details: Brief summary of contents Suggested Keywords: Target Audience Executive Director responsible for Policy: Date revised: This document replaces (exact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Name and Post Title of additional signatories Name and Signature of Divisional/Directorate Governance Lead confirming approval by specialty and divisional management meetings Signature of Executive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Details training needs, patient group within which the haematology CNS can prescribe blood components. Blood, transfusion, nurse authorisation RCHT PCH CFT KCCG Medical Director N/A N/A Haematology Transfusion Team Hospital Transfusion Committee CSSC Divisional Governance Board Sally Kennedy, Divisional Director CSSC Not required {Original Copy Signed} Name: Janet Gardner, Governance Lead CSSC {Original Copy Signed} Internet & Intranet Intranet Only Clinical / Haematology Page 7 of 10
8 Links to key external standards Related Documents: Training Need Identified? Section 130 of the 1968 Medicines Act as amended by Section 25 of the Blood Safety and Quality Regulations 2005 (SI2005 no 50). RCHT Blood transfusion Policy No Version Control Table Date Version No Summary of Changes Changes Made by (Name and Job Title) Jan 2016 V1.0 Initial Issue Caroline Edwards, Haematology CNS All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. Page 8 of 10
9 Appendix 2. Initial Equality Impact Assessment Form Name of the strategy / policy /proposal / service function to be assessed (hereafter referred to as policy) (Provide brief description): Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist Directorate and service area: Is this a new or existing Policy? Clinical Haematology New Name of individual completing Telephone: assessment: Caroline Edwards 1. Policy Aim* Who is the strategy / policy / proposal / service function aimed at? To provide a structure within which the Haematology CNS can prescribe blood components. 2. Policy Objectives* To ensure safe practice. 3. Policy intended Outcomes* 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a) Is consultation required with the workforce, equality groups, local interest groups etc. around this policy? Safe, evidence based prescribing/authorisation of blood components. Audit of compliance to policy. Haematology patients. No b) If yes, have these *groups been consulted? C). Please list any groups who have been consulted about this procedure. 7. The Impact Please complete the following table. Are there concerns that the policy could have differential impact on: Equality Strands: Yes No Rationale for Assessment / Existing Evidence Age Page 9 of 10
10 Sex (male, female, transgender / gender reassignment) Race / Ethnic communities /groups Disability - Learning disability, physical disability, sensory impairment and mental health problems Religion / other beliefs Marriage and civil partnership Pregnancy and maternity Sexual Orientation, Bisexual, Gay, heterosexual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked Yes in any column above and No consultation or evidence of there being consultation- this excludes any policies which have been identified as not requiring consultation. or Major service redesign or development 8. Please indicate if a full equality analysis is recommended. Yes No 9. If you are not recommending a Full Impact assessment please explain why. No potential for differential impact identified Signature of policy developer / lead manager / director Date of completion and submission Names and signatures of members carrying out the Screening Assessment 1. Caroline Edwards 2. Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD A summary of the results will be published on the Trust s web site. Signed Date Page 10 of 10
Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline
Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide anaesthetists with an algorithm to work with when dealing with
More informationLoading Dose Worksheet for Oral Amiodarone
This applies to adult patients only Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Prescribe as per loading dose worksheet below End 1. Aim/Purpose of this Guideline 1.1.
More informationPolicy on Governance Arrangements Relating to Medicines V2.0
V2.0 August 2015 Summary. The policy outlines the governance arrangements for medicines within the Trust, specifically; 1. The committee structure in the Trust and the county for medicine related matters
More informationCLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline To provide guidance for appropriate referral to the acute pain service for in-patient review. 2. The Guidance PAIN SERVICES
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline aims to improve outcomes for patients presenting with sepsis or developing sepsis
More informationA list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Colposcopist within Colposcopy Dept. Royal Cornwall Hospital 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse Colposcopist
More informationDiagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging
Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.
More informationCLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)
CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS) 1. Aim/Purpose of this Guideline 1.1. Pain is whatever the experiencing person says it is, existing whenever the experiencing person
More information1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Endoscopist (Lower GI) within the Royal Cornwall Hospitals Trust 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse
More information2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite
ADVANCED NEONATAL NURSE PRACTITIONERS (ANNPs) BLOOD COMPONENT AND BLOOD PRODUCT REQUESTING PROTOCOL NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 The purpose of this protocol is to guide
More informationDiagnostic Testing Procedures in Urodynamics V3.0
V3.0 09 01 18 Table of Contents Summary.... 1. Introduction... 3 1.1. Diagnostic testing information... 3 2. Purpose of this Policy/Procedure... 3 2.1. Approved Document Process... 3 3. Scope... 3 3.1.
More informationClinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline
Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist. 1. Aim/Purpose of this Guideline 1.1 This protocol applies to upper & lower GI Non medical Endoscopist
More informationCLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of for the management of Adult patients with Mellitus
More informationCLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start
CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start The non-medical practitioner has received sufficient training to make clinical
More informationCLINICAL GUIDELINE FOR: Management of low-risk upper GI haemorrhage. Page 1 of 10. Management of low-risk upper GI haemorrhage
CLINICAL GUIDELINE FOR: Page 1 of 10 Summary AGE
More informationPARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationCLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical
More informationCLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS
CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline This guideline is to support the use of bed and chair sensor alarm
More informationIBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationClinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.
Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and
More informationSchool Vision Screening Policy V2.0
School Vision Screening Policy V2.0 05 April 2016 Summary. Vision screening test in school PASS Visual acuity LogMAR 0.2 both eyes Kays 0.1 both eyes Outcome letter sent home Test result information put
More informationCLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline 1.1. Guidelines for the use of rectus sheath catheters for the management of pain following laparotomy
More informationCLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE
CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE CLINICAL GUIDELINE V4. Summary. Start The non-medical practitioner
More informationThis guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.
CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing
More informationSafe Bathing Policy V1.3
V1.3 April 2018 Summary Safe hot water temperatures The hot water distribution temperatures, which are required for the control and prevention of Legionella, can lead to discharge temperatures in excess
More informationCLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0
CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0 Page 1 of 13 Abbreviation (P/A)HDU (P/A)ICU GCS IPPV CPAP BiPAP DKA Reg Meaning (Paediatric/Adult) High Dependency
More informationNewborn Hearing Screening Programme Policy
Newborn Hearing Screening Programme Policy V3.0 December 2015 Page 1 of 16 Summary - Screening Pathway for Newborn Hearing Screening Newborn hearing screening Check eligibility Eligible for screening Not
More informationThe initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0
The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0 October 2016 Summary. Start See section 6.2 of this document for important information regarding
More informationWARD CLOSURE POLICY V
WARD CLOSURE POLICY V3.0 29.07.15 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 4 5.1.
More informationOXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0
OYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline 1.1 To provide guidance on the assessment and management of infants requiring oxygen therapy
More information2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures.
Was Not Brought, Cancellation and Refusal of Appointments Policy for Children and Young People up to the Age of 18 Years (up to the age of 25 years for people with a Learning Disability) 1. Aim/Purpose
More informationDiagnostic Testing Procedures in Neurophysiology V1.0
V1.0 10 September 2012 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the
More informationSafeguarding Children Supervision Policy V4.0. November 2016
Safeguarding Children Supervision Policy V4.0 November 2016 Page 1 of 20 Summary Part 1 Part 2 Safeguarding supervision for Nursing and Midwifery staff, Paediatricians, Medical Staff and other Allied Health
More informationMANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline
MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 This guideline aimed at all clinical staff responsible for the management of infants
More informationProcedure for the Application of a Cast and its subsequent care V1.3
Procedure for the Application of a Cast and its subsequent care V1.3 May 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary...
More informationDiagnostic Testing Procedures for Ophthalmic Science
V4.0 01/08/17 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the Managers... 3 5.3.
More informationESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline
ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline 1.1. This guidance is designed to aid staff to monitor capacity and staffing in Child Health. 2. The Guidance 2.1. The majority
More informationTissue Viability Referral Pathway. April 2017
Tissue Viability Referral Pathway V4 April 2017 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...
More informationOccupational Health Surveillance Policy V2.1
Occupational Health Surveillance Policy V2.1 May 2016 Table of Contents 1. Introduction... 2 2. Purpose of this Policy... 2 3. Scope... 2 4. Definitions/Glossary... 3 5. Ownership and Responsibilities...
More informationPRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0
PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline
More informationCLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary.
CLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary. Start Elective procedure identified, blood requirement listed in guideline Patient attends PAC and has a group and screen (G&S)
More informationCLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND
CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND 1. Aim/Purpose of this Guideline The aim of this guideline to enable the effective care of patients needing emergency defill of
More informationHealth and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0
Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0 January 2016 Summary Purpose of the document: The purpose of this policy is to provide an outline of the requirements
More informationPatient Experience Strategy
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationRCHT Non-Ionising Radiation Safety Policy
V3.0 June 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 4 4. Definitions / Glossary... 5 5. Ownership and Responsibilities... 5 6. Standards and Practice...
More informationCEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline
CEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. To provide guidance on the operation and interpretation of Cerebral Function Monitoring (CFM) in neonates.
More informationSevere Weather Plan V5.5 March 2018
V5.5 March 2018 Table of Contents 1. Introduction 3 2. Purpose of this Plan. 3 3. Scope. 3 4. Ownership and Responsibilities. 3 5. Escalation Levels and Actions 5 6. Staffing Contingency and Guidance.
More informationSafe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017
Safe Staffing Levels for Midwifery, Nursing and Support Staff For Maternity Service - Approved V1.5 June 2017 Jan Walters Head of Midwifery Women, Children and Sexual Health Division CONTENTS Section Page
More informationCLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage
CLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage Suspected Non Variceal upper GI haemorrhage If any features suggest liver disease consult the variceal haemorrhage guideline http://www.rcht.nhs.uk/documentslibrary/royalcornw
More informationHand Hygiene Policy V2.1
V2.1 October 2017 Summary. Effective hand hygiene is shown to significantly reduce the carriage of potential pathogens and decrease the risk and occurrence of healthcare associated infections. Each individual
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Version No: 5.0 Effective From: 7 September 2017 Expiry Date: 31 August 2018 Date Ratified: 30 August 2017 Ratified By: Executive Team 1 Introduction
More informationProvision of Wigs Policy
Post holder responsible for Procedural Document Author and post holder of Policy Division/Department responsible for Procedural Document Contact details Lead Cancer Nurse Tina Grose, Lead Cancer Nurse
More informationIrradiated blood products - Pathway for requesting To provide healthcare professionals with clear guidance on the use of irradiated blood products.
Document Title: Document Purpose: Document Statement: Document Application: Responsible for Implementation: Irradiated blood products - Pathway for requesting To provide healthcare professionals with clear
More informationCLINICAL GUIDELINE FOR TRANSFERS AND DISCHARGES IN THE LAST FEW WEEKS OF LIFE 1. Aim/Purpose of this Guideline
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines
The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017
More informationDrainage of Abdominal Ascites
Drainage of Abdominal Ascites Standard Operating Procedure (SOP) Prepared by: Cancer & Vascular Access Advanced Nurse Practitioner Presented to: Date: Care and Clinical Policies Group 18 January 2017 Cancer
More informationEarly detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0
Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 01.05.2018 Summary - Patient admission flow chart for the infection prevention and control of carbapenemase-producing
More informationPerson/persons conducting this assessment with Contact Details Marilyn Rees Lead VTE Nurse ext 48729
Appendix 2 - Equality Impact Assessment - Thromboprophylaxis Policy for Adult In-Patients Section A: Assessment Name of Policy Thromboprophylaxis Policy for Adult In-Patients Person/persons conducting
More informationGCP Training for Research Staff. Document Number: 005
GCP Training for Research Staff Document Number: 005 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Access to Drugs Policy Version No.: 3.0 Effective From: 25 January 2016 Expiry Date: 25 January 2019 Date Ratified: 4 November 2015 Ratified By: Medicines
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage
The Newcastle upon Tyne Hospitals NHS Foundation Trust Strong Potassium Solutions Safe Handling and Storage Version : 5.3 Effective From: 19 January 2016 Expiry Date: 19 January 2019 Date Ratified: 14
More informationHelicopter Landing Site (HLS) Policy, Procedure and Guidance (HSP025) V2.0
Helicopter Landing Site (HLS) Policy, Procedure and Guidance (HSP025) V2.0 May 2016 Summary Process for the notification of works that may require closure of the ED Helipad Project Manager (PM) identifies
More information2015 Survey of Patient Blood Management (PBM)
2015 Survey of Patient Blood Management (PBM) This is the second national Patient Blood Management (PBM) survey. In 2013 you were invited to participate in the first PBM survey which provided valuable
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationDocument Title: Training Records. Document Number: SOP 004
Document Title: Training Records Document Number: SOP 004 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Strategy for Non-Medical Prescribing Version No: 2.2 Effective From: 19 October 2016 Expiry Date: 19 October 2019 Date Ratified: 12 October 2016 Ratified
More informationPHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives
PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy
More informationNew Clinical Interventional Procedures Policy
New Clinical Interventional Procedures Policy Policy Title: Executive Summary: New Clinical Interventional Procedures Policy This document sets out East Cheshire NHS Trust s policy to ensure compliance
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact
The Newcastle upon Tyne Hospitals NHS Foundation Trust Code of Practice for Wound Care Company Representatives and Staff with whom they interact Version No.: 1.1 Effective From: 8 th January 2015 Expiry
More informationExchange Transfusion Neonatal Clinical Guideline V1.0 February 2018
Exchange Transfusion Neonatal Clinical Guideline V1.0 February 2018 1. Aim/Purpose of Guideline To help staff manage significant jaundice safely and prevent complications of brain damage and kernicterus.
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More information2015 Survey of Patient Blood Management (PBM)
2015 Survey of Patient Blood Management (PBM) This is the second national Patient Blood Management (PBM) survey. In 2013 you were invited to participate in the first PBM survey which provided valuable
More informationThe Use of Non-Invasive Ventilation in Patients with Acute Type 2 Respiratory Failure
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Employment Policies and Procedures. Breastfeeding Supporting Staff Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Employment Policies and Procedures Breastfeeding Supporting Staff Policy Version No.: 2.1 Effective From: 20 June 2018 Expiry Date: 30 June 2020 Date
More informationPolicy for Surveillance and Reporting of Infectious Disease, Healthcare Associated Infection and Antibiotic Resistant Organisms
Policy for Surveillance and Reporting of Infectious Disease, Healthcare Associated Infection and Antibiotic Resistant Organisms V5 20.09.17 Summary. Surveillance and reporting of Infectious Disease, HCAI
More informationORAL ANTI-CANCER THERAPY POLICY
ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive
More informationOther (please specify): Note: This policy has been assessed for any equality, diversity or human rights implications
Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details Judy Potter, Lead Nurse, Infection Prevention & Control Judy Potter,
More informationBlood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.
Blood Transfusion Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Clinical The policy describes the framework and principles required to deliver best transfusion
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Ventilation Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Ventilation Policy Version.: 1.0 Effective From: 15 January 2016 Expiry Date: 15 January 2019 Date Ratified: 22 December 2015 Ratified By: Estates
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationIt is essential that patients are aware of, and in agreement with, their referral to palliative care.
Title: Directorate: Responsible for review: Ratified by: CHRONIC HEART FAILURE REFERRAL TO PALLIATIVE CARE SERVCES Palliative Care Consultant in Palliative Care Care and Clinical Policies Group Ref No:
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationAccess to Health Records Procedure
Access to Health Records Procedure Version: 1.0 Ratified by: Date ratified: 11/03/2015 Name of originator/author: Name of responsible individual: Information Governance Group Medical Records Manager, Jackie
More informationPOLICY ON THE HANDLING OF CHEMOTHERAPY BY STAFF WHO ARE PREGNANT OR BREASTFEEDING
Policy on the handling of chemotherapy by staff who are pregnant/breastfeeding, v2.1 POLICY ON THE HANDLING OF CHEMOTHERAPY BY STAFF WHO ARE PREGNANT OR BREASTFEEDING Version: 2.1 Ratified by: Date ratified:
More informationAnimals and Pets in Healthcare Facilities Policy
Animals and Pets in Healthcare Facilities Policy Post holder responsible for Procedural Document Author of Guideline Division/ Department responsible for Procedural Document Contact details Judy Potter,
More informationOther (please specify): Note: This document has been assessed for any equality, diversity or human rights implications
Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details Lead Nurse/Director for Infection Prevention and Control Judy Potter,
More informationNMC programme of change for education Prescribing and standards for medicines management
NMC programme of change for education Prescribing and standards for medicines management This response form relates to our consultation on nurse and midwifery prescribing competency proposals, programme
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Mandatory Training Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Version No.: 10.0 Effective Date: 1 st July 2012 Expiry Date: 30 th June 2015 Date Ratified: 6 th June 2012 Ratified By: Executive Team Mandatory
More informationCLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)
CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration
More informationRef No: 2135 Title: Liquidised food through enteral feeding tubes in the community (Paediatric SOP) Version No: 1. Date of Issue: 10 March 2017
Ref No: 2135 Title: Liquidised food through enteral feeding tubes in the community (Paediatric SOP) Version No: 1 Originating Organisation: University Hospitals Bristol Date of Issue: 10 March 2017 Next
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Protected Mealtime Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Protected Mealtime Policy Version No 3 Effective From 12 February 2018 Expiry date 12 February 2021 Date Ratified 01 November 2017 Ratified By Nutritional
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Key Control Operational Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Key Control Operational Policy Version.: 1.0 Effective From: 18 January 2016 Expiry Date: 18 January 2019 Date Ratified: 22 December 2015 Ratified
More informationFreedom to speak up: raising concerns (whistleblowing) policy
Freedom to speak up: raising concerns (whistleblowing) policy When using this document please be sure that the version you are using is the most up to date either by checking on the Trust intranet or if
More informationDocument Title: File Notes. Document Number: 024
Document Title: File Notes Document Number: 024 Version: 1.2 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel
More informationExecutive Director of Nursing and Chief Operating Officer
Document Title Arrangements for Managing Patients Mental and Physical Health Needs across NTW and the Acute Hospital Trusts Reference Number Lead Officer Author(s) (name and designation) Ratified by NTW(C)15
More informationAdministration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016
Administration of blood components Denise Watson Patient Blood Management Practitioner 11th January, 2016 Introduction British Committee for Standards in Haematology guidelines Administration process Case
More informationRECEIPT OF APPLICATIONS FOR DETENTION UNDER THE MENTAL HEALTH ACT 1983
Reference Number: UHB 340 Version Number: 1 Date of Next Review 10 th Dec 2018 Previous Trust/LHB Reference Number: N/A RECEIPT OF APPLICATIONS FOR DETENTION UNDER THE MENTAL HEALTH ACT 1983 Introduction
More information